Biotech,raised properly
Platform or asset, preclinical or clinical, the raise gets built around what the next milestone proves and what it costs.
What is different about raising in biotech
Platform stories need one lead asset. Committees fund a lead programme and inherit the platform.
Preclinical data packages are diligenced by scientific advisers who will ask for the raw data, not the summary chart.
Syndicate construction matters as much as the pitch: who leads, who follows, who has reserves.
The engine behind the raise
Capital types we most often work across here: Venture capital, EIS and SEIS, Strategic and corporate.
- Lead asset narrative with the platform positioned behind it
- Data package indexed for scientific diligence
- Syndicate map: leads, followers and reserve capacity
- EIS and SEIS support where applicable, and grant income positioned correctly
- Investor operations through to close, with a full promotion audit trail
The questions capital will ask
If you cannot answer these with evidence in the data room, the process stalls at week two.
- What is the lead programme, and what stage is it at?
- What does the next milestone cost, and how long does it take?
- Who are the scientific advisers, and can diligence speak to them?
- Have any institutional or strategic investors already committed?
We work across private markets
Fintech
Payments, lending, wealth infrastructure and embedded finance, raised with materials that survive a diligence team who already knows the sector.
View sectorDeeptech
Hard science, long horizons and technical risk, presented so a generalist committee can underwrite what a specialist already understands.
View sectorTechnology and software
SaaS, marketplaces and platforms, raised on metrics that reconcile to the accounts rather than to a slide.
View sectorLife sciences
Clinical, regulatory and reimbursement risk explained in one sequence a committee can underwrite.
View sectorHealthtech
Digital health and care technology, raised on adoption evidence, procurement reality and a credible route to contracted revenue.
View sectorEngineering and industrials
Manufacturing, advanced engineering and industrial businesses, raised on order book, capacity and the capex plan behind them.
View sectorCleantech and energy transition
Where technology risk meets project risk, raised with the structure, offtake and permitting position resolved before outreach begins.
View sectorInfrastructure projects
Shovel-ready or nearly there, raised on planning, permits, offtake and a contracting structure that stands up to lender diligence.
View sectorReal estate
Development and income strategies, raised on site control, planning status, debt position and a stated exit.
View sectorPrivate credit
Borrowers and sponsors raising private debt, presented with the security package, coverage and covenant position resolved up front.
View sectorSustainable Wealth Group is not authorised or regulated by the Financial Conduct Authority. Nothing on this page is advice, or an invitation or inducement to engage in investment activity. Capital at risk.